Visterra

Visterra

Developing transformative biologics for immune-mediated and hard-to-treat diseases. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€170—255m (Dealroom.co estimates Oct 2017.)
Cambridge Massachusetts (HQ)
Authorizing premium user...